Literature DB >> 16088413

Intravenous nicotine self-administration in rats: effects of mecamylamine, hexamethonium and naloxone.

Victor J DeNoble1, Paul C Mele.   

Abstract

The rate and pattern of lever pressing were studied in 18 rats during 24-h sessions in which responding resulted in intravenous infusions of nicotine. There were four indications of the positive reinforcing effect of nicotine: (1) a greater number of lever presses when nicotine was response-contingent compared to when saline was available; (2) a greater number of responses on the lever resulting in an infusion of nicotine than on the control lever; (3) systematic decreases in the number of contingent nicotine infusions when nicotine was delivered noncontingently; and (4) systematic changes in the frequency of lever pressing as a function of dose. Under a fixed ratio 1 (FR 1) schedule, the number of infusions first increased and then decreased as the dose of nicotine was decreased (64, 32, 16, and 8 microg/kg infusion) and nicotine intake (mg/kg every 24 h) was directly related to the infusion dose. As the FR size was increased from 1 to 6, the number of lever presses increased and the number of infusions (32 microg/kg) remained stable. At FR values greater than 6, both the number of lever presses and infusions decreased. Presession injections of mecamylamine (0.75, 1.5, and 3.0 mg/kg, s.c.) decreased the number of infusions in a dose-related manner. Presession injections of hexamethonium (1.5 and 3.0 mg/kg, s.c.) or naloxone (0.75, 1.5, and 3.0 mg/kg, s.c.) did not alter the within- or between-session patterns of nicotine self-administration. Under the conditions of the present experiment, nicotine served as an effective reinforcer and the behavior was shown to be sensitive to both FR size and infusion dose. In addition, the results suggest that nicotine self-administration involves central nicotinic receptors and that opioid receptor antagonism has no effect on nicotine's reinforcing effects in rats.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16088413     DOI: 10.1007/s00213-005-0054-z

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  32 in total

Review 1.  Schedule-induced physical dependence on ethanol.

Authors:  J L Falk; H H Samson
Journal:  Pharmacol Rev       Date:  1975-12       Impact factor: 25.468

2.  Studies on the time course and the effect of cholinergic and adrenergic receptor blockers on the stimulus effect of nicotine.

Authors:  I D Hirschhorn; J A Rosecrans
Journal:  Psychopharmacologia       Date:  1974

3.  Behavioral effects of separate and combined administration of naloxone and d-amphetamine.

Authors:  S G Holtzman
Journal:  J Pharmacol Exp Ther       Date:  1974-04       Impact factor: 4.030

4.  Effects of nicotine on fixed-interval behavior and their modification by cholinergic antagonists.

Authors:  M Stitzer; J Morrison; E F Domino
Journal:  J Pharmacol Exp Ther       Date:  1970-02       Impact factor: 4.030

5.  Effects of nicotine on several schedules of behavior in rats.

Authors:  S N Pradhan
Journal:  Arch Int Pharmacodyn Ther       Date:  1970-01

6.  Self-administered nicotine solutions preferred to placebo by the rat.

Authors:  M S Clark
Journal:  Br J Pharmacol       Date:  1969-02       Impact factor: 8.739

7.  Novel phenylpiperidine opioid antagonists and partial agonists: effects on fluid consumption.

Authors:  J D Leander; J C Hart; M A Lochner; M D Hynes; D M Zimmerman
Journal:  Eur J Pharmacol       Date:  1982-07-09       Impact factor: 4.432

8.  Schedule induced self injections of nicotine with recovered body weight.

Authors:  G Singer; F Simpson; W J Lang
Journal:  Pharmacol Biochem Behav       Date:  1978-09       Impact factor: 3.533

9.  Persistent behavior at high rates maintained by intravenous self-administration of nicotine.

Authors:  S R Goldberg; R D Spealman; D M Goldberg
Journal:  Science       Date:  1981-10-30       Impact factor: 47.728

10.  beta-Endorphin is associated with overeating in genetically obese mice (ob/ob) and rats (fa/fa).

Authors:  D L Margules; B Moisset; M J Lewis; H Shibuya; C B Pert
Journal:  Science       Date:  1978-12-01       Impact factor: 47.728

View more
  52 in total

1.  Comparative effects of dextromethorphan and dextrorphan on nicotine discrimination in rats.

Authors:  M Jerry Wright; Robert E Vann; Thomas F Gamage; M Imad Damaj; Jenny L Wiley
Journal:  Pharmacol Biochem Behav       Date:  2006-11-16       Impact factor: 3.533

2.  A lack of association between severity of nicotine withdrawal and individual differences in compensatory nicotine self-administration in rats.

Authors:  Andrew C Harris; Paul R Pentel; Danielle Burroughs; Mylissa D Staley; Mark G Lesage
Journal:  Psychopharmacology (Berl)       Date:  2011-04-15       Impact factor: 4.530

Review 3.  Nicotine reduction revisited: science and future directions.

Authors:  Dorothy K Hatsukami; Kenneth A Perkins; Mark G Lesage; David L Ashley; Jack E Henningfield; Neal L Benowitz; Cathy L Backinger; Mitch Zeller
Journal:  Tob Control       Date:  2010-10       Impact factor: 7.552

Review 4.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

5.  Sex differences in nicotine self-administration in rats during progressive unit dose reduction: implications for nicotine regulation policy.

Authors:  Patricia Grebenstein; Danielle Burroughs; Yan Zhang; Mark G LeSage
Journal:  Pharmacol Biochem Behav       Date:  2013-11-04       Impact factor: 3.533

6.  Mutually augmenting interactions of dextromethorphan and sazetidine-A for reducing nicotine self-administration in rats.

Authors:  Edward D Levin; Corrine Wells; Susan Slade; Amir H Rezvani
Journal:  Pharmacol Biochem Behav       Date:  2018-01-31       Impact factor: 3.533

7.  Initial Cross-Over Test of A Positive Allosteric Modulator of Alpha-7 Nicotinic Receptors to Aid Cessation in Smokers With Or Without Schizophrenia.

Authors:  Kenneth A Perkins; K N Roy Chengappa; Joshua L Karelitz; Margaret C Boldry; Valerie Michael; Taylor Herb; Jessica Gannon; Jaspreet Brar; Lisa Ford; Stefanie Rassnick; Darlene H Brunzell
Journal:  Neuropsychopharmacology       Date:  2017-11-29       Impact factor: 7.853

8.  Naltrexone attenuation of conditioned but not primary reinforcement of nicotine in rats.

Authors:  Xiu Liu; Matthew I Palmatier; Anthony R Caggiula; Alan F Sved; Eric C Donny; Maysa Gharib; Sheri Booth
Journal:  Psychopharmacology (Berl)       Date:  2008-09-21       Impact factor: 4.530

Review 9.  Abuse liability assessment of tobacco products including potential reduced exposure products.

Authors:  Lawrence P Carter; Maxine L Stitzer; Jack E Henningfield; Rich J O'Connor; K Michael Cummings; Dorothy K Hatsukami
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

Review 10.  Effects of nicotine in experimental animals and humans: an update on addictive properties.

Authors:  Bernard Le Foll; Steven R Goldberg
Journal:  Handb Exp Pharmacol       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.